Agonist-dependent variablity of contributions of nitric oxide and prostaglandins in human skeletal muscle

Journal of Applied Physiology

Volumn 98, Issue 4, 2005, Pages 1251-1257

  Schrage, William G ^a   Dietz, Niki M ^a   Eisenach, John H ^a   Joyner, Michael J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Brachial artery; Cyclooxygenase; Human endothelium; Intra arterial infusion

Indexed keywords

ACETYLCHOLINE; BRADYKININ; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; KETOROLAC; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

ADULT; ARTICLE; BRACHIAL ARTERY; CLAMP; CONTROLLED STUDY; ENDOTHELIUM; ENZYME INHIBITION; FEMALE; FOREARM BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; HYPOTHESIS; LIMB; MALE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; SKELETAL MUSCLE; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

ACETYLCHOLINE; ADULT; BLOOD FLOW VELOCITY; BRADYKININ; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MUSCLE, SKELETAL; NITRIC OXIDE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; SENSITIVITY AND SPECIFICITY; VASODILATION; VASODILATOR AGENTS;

EID: 15444377312     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00966.2004     Document Type: Article

References (36)

1. + channels by cytochrome P-450 inhibitors. J Biol Chem 267: 11789-11793, 1992.
2. Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, and Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 94: 3341-3347, 1996.
3. Brandes RP, Schmitz-Winnenthal FH, Feletou M, Godecke A, Huang PL, Vanhoutte PM, Fleming I, and Busse R. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci USA 97: 9747-9752, 2000.
4. 2 receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway. Circulation 102: 2190-2196, 2000.
5. Buckley MM and Brogden RN. Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 39: 86-109, 1990.
6. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, and Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci 23: 374-380, 2002.
7. Campia U, Choucair WK, Bryant MB, Quyyumi AA, Cardillo C, and Panza JA. Role of cyclooxygenase products in the regulation of vascular tone and in the endothelial vasodilator function of normal, hypertensive, and hypercholesterolemic humans. Am J Cardiol 89: 286-290, 2002.
8. Coats P, Johnston F, MacDonald J, McMurray JJV, and Hillier C. Endothelium-derived hyperpolarizing factor: identification and mechanisms of action in human subcutaneous resistance arteries. Circulation 103: 1702-1708, 2001.
9. G-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm. Br J Clin Pharmacol 38: 307-310, 1994.
10. G-monomethyl-L-argimne of responses to endothelium-dependent vasodilators in human forearm vasculature. Br J Pharmacol 134: 939-944, 2001.
11. DeSouza CA, Clevenger CM, Greiner JJ, Smith DT, Hoetzer GL, Shapiro LF, and Stauffer BL. Evidence for agonist-specific endothelial vasodilator dysfunction with ageing in healthy humans. J Physiol 542: 255-262, 2002.
12. Engelke KA, Halliwill JR, Proctor DN, Dietz NM, and Joyner MJ. Contribution of nitric oxide and prostaglandins to reactive hyperemia in human forearm. J Appl Physiol 81: 1807-1814, 1996.
13. Fichtlscherer S, Dimmeler S, Breuer S, Busse R, Zeiher AM, and Fleming I. Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease. Circulation 109: 178-183, 2004.
14. Gillis JC and Brogden RN. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs 53: 139-188, 1997.
15. Greenfield ADM, Whitney RJ, and Mowbray JF. Methods for the investigation of peripheral blood flow. Br Med Bull 19: 101-109, 1963.
16. Halcox JP, Narayanan S, Cramer-Joyce L, Mincemoyer R, and Quyyumi AA. Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation. Am J Physiol Heart Clrc Physiol 280: H2470-H2477, 2001.
17. Honing ML, Smits P, Morrison PJ, and Rabelink TJ. Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization. Hypertension 35: 1314-1318, 2000.
18. Inokuchi K, Hirooka Y, Shimokawa H, Sakai K, Kishi T, Ito K, Kimura Y, and Takeshita A. Role of endothelium-derived hyperpolarizing factor in human forearm circulation. Hypertension 42: 919-924, 2003.
19. Katz SD, Schwarz M, Yuen J, and Lejemtel TH. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Circulation 88: 55-61, 1993.
20. Meeking DR, Browne DL, Allard S, Munday J, Chowienczyck PJ, Shaw KM, and Cummings MH. Effects of cyclo-oxygenase inhibition on vasodilatory response to acetylcholine in patients with type 1 diabetes and nondiabetic subjects. Diabetes Care 23: 1840-1843, 2000.
21. + channels. Circ Res 83: 501-507, 1998.
22. G-nitro-L-arginine in rats. Am J Physiol Heart Circ Physiol 263: H1090-H1094, 1992.
23. Newcomer SC, Leuenberger UA, Hogeman CS, Handly BD, and Proctor DN. Different vasodilator responses of human arms and legs. J Physiol 556: 1001-1011, 2004.
24. Nishikawa Y, Stepp DW, and Chilian WM. Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am J Physiol Heart Circ Physiol 279: H459-H465. 2000.
25. G-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm. Br J Clin Pharmacol 38: 311-315, 1994.
26. Osanai T, Fujita N, Fujiwara N, Nakano T, Takahashi K, Guan W, and Okumura K. Cross talk of shear-induced production of prostacyclin and nitric oxide in endothelial cells. Am J Physiol Heart Circ Physiol 278: H233-H238, 2000.
27. Panza JA, Garcia CE, Kilcoyne CM, Quyyumi AA, and Cannon RO 3rd. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 91: 1732-1738, 1995.
28. Passauer J, Bussemaker E, Lassig G, Pistrosch F, Fauler J, Gross P, and Fleming I. Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole. Clin Sci (Lond) 105: 513-518, 2003.
29. Sofola OA, Knill A, Hainsworth R, and Drinkhill M. Change in endothelial function in mesenteric arteries of Sprague-Dawley rats fed a high salt diet. J Physiol 543: 255-260, 2002.
30. Taddei S, Galetta F, Virdis A, Ghiadoni L, Salvetti G, Franzoni F, Giusti C, and Salvetti A. Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. Circulation 101: 2896-2901, 2000.
31. Taddei S, Virdis A, Ghiadoni L, Magagna A, and Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension 29: 274-279, 1997.
32. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, and Salvetti A. Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38: 274-279, 2001.
33. Taddei S, Virdis A, Mattei P, Ghiadoni L, Fasolo CB, Sudano I, and Salvetti A. Hypertension causes premature aging of endothelial function in humans. Hypertension 29: 736-743, 1997.
34. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, Sudano I, and Salvetti A. Aging and endothelial function in normotensive. subjects and patients with essential hypertension. Circulation 91: 1981-1987, 1995.
35. Taddei S, Virdis A, Mattei P, and Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 21: 929-933, 1993.
36. Wilson JR and Kapoor SC. Contribution of prostaglandins to exercise-induced vasodilation in humans. Am J Physiol Heart Circ Physiol 265: H171-H175, 1993.